For independent reps & small medtech teams
Know every surgeon's volume. Skip the $30k contract.
DocVol ranks the surgeons in your territory by real Medicare procedure volumes and shows which device companies already pay them — the same federal data the enterprise platforms resell, at 1/10th the price.
No demo call · No sales rep · No annual lock-in
| # | Surgeon | Cases/yr | Momentum |
|---|---|---|---|
| 1 | Kenneth Kaminski, MD | 275 | ▼ -12% |
| 2 | Christopher Phelps, MD | 237 | ▲ +10% |
| 3 | David Shephard, MD | 221 | ▲ +19% |
| 4 | Stefan Kreuzer, MD | 173 | ▼ -13% |
| 5 | Bruce Simpson, MD | 157 | ▲ +83% |
The toolkit
Everything a rep needs to own a territory
Find the right surgeons, understand who already owns them, and walk into every meeting prepared — six tools in one workflow.
Volume search + momentum
Every surgeon in any state, ranked by real Medicare cases — with ▲▼ badges showing who's rising and who's cooling year-over-year.
Try a search →Competitor payment intel
Fresh CY2025 Open Payments on every profile: who pays each surgeon, how much, and the 2019–2025 trajectory. High volume + low payments = whitespace.
See a profile →AI Territory Consultant
“Build me a call plan for Dallas knees.” Answers pulled live from DocVol's data — never from memory — ending with today's next step. Always one click away, on every page.
Ask a question →Territory Intel reports
Auto-generated intent signals per state: rising surgeons (future KOLs), new entrants, cooling accounts — plus live FDA clearances and recalls.
See a live report →Targets + call briefs
Star surgeons into a working list with call notes, then print a one-page brief before any meeting: volumes, ties, affiliations, live phone.
How it works →CRM-ready exports
HubSpot and Salesforce import formats with zero remapping, enriched with practice phone verified same-day against the NPPES registry.
Export a list →
Territory Intel · Cardiology · FL
🔥 12 rising TAVR operators ▲ up to +185%
Why reps switch
Signals the $50k platforms don't surface
- ▲Momentum, not just volume. A surgeon at 157 cases growing +83% is a better call than one at 275 declining — DocVol is built around that difference.
- ◎Whitespace detection. High volume + low competitor payments = an open door. The 7-year payment trajectory shows whether a rival's grip is tightening or slipping.
- ◷Date-stamped honesty. Live NPPES contact checks, CY2025 payments, the latest federal claims release — every number labeled with its vintage. If a vendor won't tell you how old their data is, ask why.
Built against everything reps hate about the incumbents
| Enterprise platforms | DocVol | |
|---|---|---|
| Pricing | "Book a demo" — $14.8k to $260k/yr | $199/mo, published right here |
| Contract | Multi-year, auto-renewing | Month-to-month, cancel anytime |
| Data freshness | Undisclosed lag | Vintage labeled on every screen |
| Who can buy | Companies with procurement teams | Anyone with a credit card |
Comparing options? Read our honest takes: AcuityMD · Definitive Healthcare · MedScout · Alpha Sophia
Who it's for
Built for the field, not the boardroom
You don't need a 40-module platform to plan Tuesday's calls. You need the ranked list, the competitor intel, and a CSV that drops into your CRM. That's DocVol — and it costs less per month than one steak dinner with a surgeon.
Try it on your territoryTransparent pricing
Month-to-month. Cancel anytime. Annual = 2 months free.
Solo
For independent 1099 reps
$199/mo
- ✓ Unlimited surgeon search
- ✓ All tracked procedures
- ✓ Industry payment intel (Open Payments)
- ✓ AI Territory Consultant (40 questions/day)
- ✓ Saved target lists + call notes
- ✓ Printable call briefs (one-pager per surgeon)
- ✓ CSV export
Team
For 1–20 rep manufacturers
$599/mo
- ✓ Everything in Solo
- ✓ 5 seats included
- ✓ Territory Intel — automated intent reports (rising, new & cooling surgeons)
- ✓ Shared territory lists
- ✓ CRM-ready exports (HubSpot & Salesforce formats)
Frequently asked questions
- What is DocVol?
- DocVol is a self-serve sales-intelligence platform for medical-device reps and small medtech teams. It ranks U.S. surgeons by real Medicare procedure volumes, shows year-over-year momentum, and reveals which manufacturers already pay each surgeon — starting at $199/month with no demo calls or annual contracts.
- Where does DocVol's data come from?
- Four public federal sources: CMS Medicare Physician & Other Practitioners claims (procedure volumes), CMS Open Payments (industry payments, CY2025), the live NPPES registry (current practice address and phone), and CMS Doctors & Clinicians (hospital affiliations). Every screen is labeled with its data vintage.
- How is DocVol different from AcuityMD, Definitive Healthcare, or MedScout?
- Those platforms are excellent for enterprises — and priced like it ($14.8k–$260k/year, demo-gated, multi-year contracts). DocVol is built for individual reps and 1–20 rep teams: transparent pricing, credit-card signup, month-to-month billing, and the targeting signals that matter in the field.
- Does DocVol cover my specialty?
- DocVol tracks 74 device-heavy procedures across eight specialties: orthopedics (joints, spine, trauma, sports, foot & ankle), cardiology (rhythm, structural heart, coronary, EP, vascular), ophthalmology (cataract, MIGS, retina), urology (BPH, stones, oncology), GI & general surgery (endoscopy, ERCP, lap/robotic), pain & neuromodulation (SCS, DBS, RFA, kyphoplasty), vein & wound care (ablation, skin substitutes) and ENT (FESS, balloon sinuplasty, cochlear implants). More are added regularly — ask via the request widget.
- Are the volumes complete?
- Volumes reflect traditional Medicare (fee-for-service Part B) claims — the freshest physician-level data that exists publicly. They exclude Medicare Advantage and commercial claims, so use them as rankings and momentum signals rather than absolute totals. No vendor has newer physician-level claims; DocVol is simply transparent about it.
- Can I cancel anytime?
- Yes. Billing is month-to-month through Stripe and you can cancel from your account page in two clicks. No multi-year lock-in, no auto-renewing contracts, no price escalators.